During the Jefferies 2nd Annual Healthcare Conference in New York, David S. Barlow, the chairman and CEO of Molecular Insight Pharmaceuticals, Inc. (MIPI) presented on the fast growing field of molecular medicine. The company specializes in the emerging field of molecular medicine, focusing on utilizing innovations within the identification and targeting of disease at the molecular level to improve healthcare for patients with life-threatening diseases.